open
serve
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
News
Discover
Civics
Toggle civics trackers
Markets
Ask Genius
Apps
IJR News — today's news from every side
Ask Genius
Apps
Trending ▾
x/genentech
— 3h
Hanmi Genentech obesity drug deal worth $2.3B reported
Hanmi Pharmaceutical has signed an exclusive, worldwide license with Genentech for HM17321, a long-acting UCN2 analog aimed at obesity that promises weight loss with muscle preservation, with Genentech taking over development from Phase 2 onward outside Korea. The deal could reach about $2.3 billion, including a $190 million upfront, up to $2.1 billion in milestones, and future royalties, subject to U.S. antitrust clearance and successful clinical progression.
14 sources · 3h